08-05-2025 22:07 via medpagetoday.com

Oral IBAT Inhibitor Improves Cholestatic Itch in Primary Biliary Cholangitis

(MedPage Today) -- Linerixibat, an investigational oral ileal bile acid transporter (IBAT) inhibitor, improved cholestatic pruritus in patients with primary biliary cholangitis (PBC), the randomized phase III GLISTEN trial showed.
Among 238 patients...
Read more »

Medical Industry news



One Bariatric Surgery Procedure Better for the Heart?
U.S. Infant Mortality Dropped in 2024. Experts Partly Credit RSV Shots.
Smoke From Climate-Fueled Wildfires Contributes to Thousands of U.S. Deaths
Risk of Neurological Disorder Rises for People Who Live Near Golf Courses
Risk of Neurologic Disorder Rises for People Who Live Near Golf Courses
Multiple Cancers Occurring More Often in Younger Age Groups
Trump's HHS Deputy Secretary Pick Breezes Through Senate Hearing
Nurses Week Goes Viral; Ob/Gyn Reacts to Met Gala; 24 Hours in an Empty Hospital
Here's Why Kennedy Says the Mumps Vaccine Doesn't Work
Ultraprocessed Foods Tied to Early Parkinson's Disease Symptoms
FDA OKs Combination for Low-Grade Serous Ovarian Cancer
Trump's Gain-of-Function Order Prompts Questions
Plastic Stents on Par With LAMS for Pancreatic Pseudocyst Drainage
Investigational Oral Microbiome Drug Safe, Tolerable for IBS With Constipation
Desktop versie